Next Article in Journal
In Vivo Electroporation-Mediated, Intrahepatic Alpha1 Antitrypsin Gene Transfer Reduces Pulmonary Emphysema in Pallid Mice
Next Article in Special Issue
Click-Free Synthesis of a Multivalent Tricyclic Peptide as a Molecular Transporter
Previous Article in Journal
Protein Expression Knockdown in Cancer Cells Induced by a Gemini Cationic Lipid Nanovector with Histidine-Based Polar Heads
Previous Article in Special Issue
An Enteric-Coated Polyelectrolyte Nanocomplex Delivers Insulin in Rat Intestinal Instillations When Combined with a Permeation Enhancer
Open AccessArticle

Cyclic Peptide-Gadolinium Nanoparticles for Enhanced Intracellular Delivery

Department of Pharmaceutical Sciences, College of Pharmacy, Marshall B. Ketchum University, Fullerton, CA 92831, USA
Center for Targeted Drug Delivery, Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Harry and Diane Rinker Health Science Campus, Irvine, CA 92618, USA
School of Biotechnology, KIIT Deemed to be University, Bhubaneswar 751024, India
Faculty of Pharmacy, University of Central Punjab, Lahore 54000, Pakistan
Authors to whom correspondence should be addressed.
Pharmaceutics 2020, 12(9), 792;
Received: 23 July 2020 / Revised: 16 August 2020 / Accepted: 19 August 2020 / Published: 21 August 2020
(This article belongs to the Special Issue Peptide-Based Drug Delivery Systems)
A cyclic peptide containing one cysteine and five alternating tryptophan and arginine amino acids [(WR)5C] was synthesized using Fmoc/tBu solid-phase methodology. The ability of the synthesized cyclic peptide to produce gadolinium nanoparticles through an in situ one-pot mixing of an aqueous solution of GdCl3 with [(WR)5C] peptide solution was evaluated. Transmission electron microscopy showed the formed peptide-Gd nanoparticles in star-shape morphology with a size of ~250 nm. Flow cytometry investigation showed that the cellular uptake of a cell-impermeable fluorescence-labeled phosphopeptide (F′-GpYEEI, where F′ = fluorescein) was approximately six times higher in the presence of [(WR)5C]-Gd nanoparticles than those of F′-GpYEEI alone in human leukemia adenocarcinoma (CCRF-CEM) cells after 2 h incubation. The antiproliferative activities of cisplatin and carboplatin (5 µM) were increased in the presence of [(WR)5C]-GdNPs (50 μM) by 41% and 18%, respectively, after 72-h incubation in CCRF-CEM cells. The intracellular release of epirubicin, an anticancer drug, from the complex showed that 15% and 60% of the drug was released intracellularly within 12 and 48 h, respectively. This report provides insight about using a non-toxic MRI agent, gadolinium nanoparticles, for the delivery of various types of molecular cargos. View Full-Text
Keywords: drug delivery systems; cyclic peptides; gadolinium nanoparticles; intracellular transportation; nanocarriers drug delivery systems; cyclic peptides; gadolinium nanoparticles; intracellular transportation; nanocarriers
Show Figures

Graphical abstract

MDPI and ACS Style

Shirazi, A.N.; Park, S.E.; Rad, S.; Baloyan, L.; Mandal, D.; Sajid, M.I.; Hall, R.; Lohan, S.; Zoghebi, K.; Parang, K.; Tiwari, R.K. Cyclic Peptide-Gadolinium Nanoparticles for Enhanced Intracellular Delivery. Pharmaceutics 2020, 12, 792.

AMA Style

Shirazi AN, Park SE, Rad S, Baloyan L, Mandal D, Sajid MI, Hall R, Lohan S, Zoghebi K, Parang K, Tiwari RK. Cyclic Peptide-Gadolinium Nanoparticles for Enhanced Intracellular Delivery. Pharmaceutics. 2020; 12(9):792.

Chicago/Turabian Style

Shirazi, Amir N.; Park, Shang E.; Rad, Shirin; Baloyan, Luiza; Mandal, Dindyal; Sajid, Muhammad I.; Hall, Ryley; Lohan, Sandeep; Zoghebi, Khalid; Parang, Keykavous; Tiwari, Rakesh K. 2020. "Cyclic Peptide-Gadolinium Nanoparticles for Enhanced Intracellular Delivery" Pharmaceutics 12, no. 9: 792.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop